Willingness to pay to assess patient preferences for therapy in a Canadian setting

被引:45
|
作者
Marra, CA
Frighetto, L
Goodfellow, AF
Wai, AO
Chase, ML
Nicol, RE
Leong, CA
Tomlinson, S
Ferreira, BM
Jewesson, PJ [1 ]
机构
[1] Vancouver Hosp & Hlth Sci Ctr, Pharmaceut Sci Clin Serv Unit, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1186/1472-6963-5-43
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Adult outpatient parenteral antibiotic therapy (OPAT) programs have been reported in the literature for over 20 years, however there are no published reports quantifying preference for treatment location of patients referred to an OPAT program. The purpose of this study was to elicit treatment location preferences and willingness to pay (WTP) from patients referred to an OPAT program. Methods: A multidisciplinary, single centre, prospective study at a 1000-bed Canadian adult tertiary care teaching hospital. This study involved a WTP questionnaire that was administered over a 9-month study period. Eligible and consenting patients referred to the OPAT program were asked to state their preference for treatment location and WTP for a hypothetical treatment scenario involving intravenous antibiotic therapy. Multiple linear regression analysis was performed to determine predictors of WTP. Results: Of 131 eligible patients, 91 completed the WTP questionnaire. The majority of participants were males, married, in their sixth decade of life and had a secondary school education or greater. The majority of participants were retired or they were employed with annual household incomes less than $60,000. Osteomyelitis was the most common type of infection for which parenteral therapy was required. Of those 87 patients who indicated a preference, 77 (89%) patients preferred treatment at home, 10 (11%) patients preferred treatment in hospital. Seventy-one (82%) of these patients provided interpretable WTP responses. Of these 71 patients, 64 preferred treatment at home with a median WTP of $490 CDN ( mean $949, range $20 to $6250) and 7 preferred treatment in the hospital with a median WTP of $500 CDN ( mean $1123, range $10 to $3000). Tests for differences in means and medians revealed no differences between WTP values between the treatment locations. The total WTP for the seven patients who preferred hospital treatment was $7,859 versus $60,712 for the 64 patients who preferred home treatment. Income and treatment location preference were independent predictors of WTP. Conclusion: This study reveals that treatment at home is preferred by adult inpatients receiving intravenous antibiotic therapy that are referred to our OPAT program. Income and treatment location appear to be independently associated with their willingness to pay.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Hunter Preferences and Willingness to Pay for Hunting Leases
    Munn, Ian
    Hussain, Anwar
    Hudson, Darren
    West, Ben C.
    FOREST SCIENCE, 2011, 57 (03) : 189 - 200
  • [22] Consumer preferences and willingness to pay for organic apples
    Cerda, Arcadio A.
    Garcia, Leidy Y.
    Ortega-Farias, Samuel
    Ubilla, Alvaro M.
    CIENCIA E INVESTIGACION AGRARIA, 2012, 39 (01): : 47 - 59
  • [23] Preferences and willingness to pay for GM labeling policies
    Loureiro, ML
    Hine, S
    FOOD POLICY, 2004, 29 (05) : 467 - 483
  • [24] Consumer Preferences and Willingness to Pay for Public Goods
    Beata, Mikusova Merickova
    Nikoleta, Muthova
    PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE CURRENT TRENDS IN PUBLIC SECTOR RESEARCH, 2018, : 83 - 90
  • [25] FACTORS IMPACTING PERSONALIZED MEDICINE TEST ADOPTION: EVALUATING PATIENT PREFERENCES AND WILLINGNESS TO PAY
    Canestaro, W. J.
    Regier, D. A.
    Veenstra, D. L.
    Lavallee, D.
    Basu, A.
    Carlson, J. J.
    VALUE IN HEALTH, 2015, 18 (03) : A112 - A112
  • [26] Using willingness-to-pay to establish patient preferences for cancer testing in primary care
    Sandra Hollinghurst
    Jonathan Banks
    Lin Bigwood
    Fiona M. Walter
    Willie Hamilton
    Tim J. Peters
    BMC Medical Informatics and Decision Making, 16
  • [27] Patient preferences and willingness to pay for enhancements to subcutaneous injection devices used to treat psoriasis
    Cividino, Alfred
    Signorovitch, James E.
    Skup, Martha
    Tundia, Namita
    Mulani, Parvez
    Arulmani, Udayasankar
    Bao, Yanjun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB178 - AB178
  • [28] Patient preferences and willingness to pay for inpatient care by primary care physicians versus hospitalists
    Meltzer, DO
    Hertko, JM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 254A - 254A
  • [29] HOW DOES OSTEOARTHRITIS SEVERITY INFLUENCE PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR OSTEOARTHRITIS TREATMENTS?
    Hufstader, M.
    White-Means, S.
    Gourley, D.
    Mele, N.
    Yang, Y.
    Hong, S. H.
    VALUE IN HEALTH, 2011, 14 (03) : A130 - A130
  • [30] Measuring patient preferences for ancillary testing: Patient willingness-to-pay for immunohistochemistry in tumors of unknown origin
    Pirain, DM
    Grzybicki, DM
    Andrew-Ja-Ja, C
    Raab, SS
    MODERN PATHOLOGY, 2005, 18 : 324A - 325A